Express Pharma Pulse

India's No.1 Weekly For The Pharmaceutical Industry

About us || Feedback|| Advertising || Subscribe || Archives / Search

Issue dated - 18th August 2005

[an error occurred while processing this directive]

Latest News

404 - Error: 404

Navigation

An error has occurred.
The requested page cannot be found.

Home Page

If difficulties persist, please contact the System Administrator of this site and report the error below.

#404 Category not found

News Archives >>

Mergers and acquisitions in Pharma
Preserving the Cord of Life

The Next Big Destination
Come next month and the much-awaited International Biotech Park (IBP) in Pune-the Silicon Valley of western India-will be ready for operations. Prasanta Biswal, Chief Executive Officer, IBP reveals in an exclusive to Divya Nair, what makes this business park unique.

INSIDE PHARMA

COVER STORY

IN THE NEWS

IN-DEPTH

TECHNOLOGY TRENDZ

HEALTH NEWS

CORPORATE

MARKET PLACE

CONVERSATION

[an error occurred while processing this directive]

IN THE NEWS	IN-DEPTH
American weight loss product launched in Bangalore The New Delhi based Ochoa Laboratories has introduced ‘Amylofix’ an American brand of weight loss product extracted from bikidney beans (Phaseolus vulgaris) in the Indian market. The formal launch was held in the city recently.	Stem cells: Beyond embryonic stage The uncertain regulatory environment in the US might have raised ethical and religious issues relating to stem cell research some forms of research involve using human embryos. However, stem cell technology is the next big wave and a buzzword in the scientific community in India. There has been increasing activity in stem cell research in recent times in both public and private sectors and there are no political or faith-based objections.
TECHNOLOGY TRENDZ	HEALTH NEWS
Chemical Drug Delivery Systems: Strategies And Applications Despite the considerable progress of the last century, rational drug design that allows the development of effective pharmaceutical agents with minimal side effects remains an elusive goal. Many therapeutic drugs have undesirable properties that may become pharmacological, pharmaceutical or pharmacokinetic barriers in clinical drug applications.	Indian Nursing Council plans a slew of initiatives In a bid to boost the nursing sector, the Indian Nursing Council (INC), the parent body of the nursing councils in the country, has rolled out a series of initiatives, many of which are in the early implementation stage, while the rest have been forwarded by INC for approval to the Union Health ministry.
CORPORATE	MARKETPLACE
Humalog Mixture is the latest innovation in diabetes care Eli Lilly brings a first of its kind insulin mixture that caters specifically to the Indian patient.	Sun Pharma gets stake in Valeant Sun Pharmaceutical Industries has said that it had acquired a stake in ICN Company Hungary from Valeant Pharma-ceuticals International. The purchase of the raw materials and dosage form manufacturing operations in Hungary gave Sun an early opportunity to enter the European generic market, its Chairman Dilip Shanghvi said in a statement.
CONVERSATION
‘Ensuring data protection is crucial for clinical activity’ Incorporated in India in 1994, Roche Scientific Company (India), is a wholly owned subsidiary of the Basel (Switzerland)-based F Hoffmann LA Roche (FHLR). In 1993, FHLR entered into an agreement with Nicholas Piramal India to market and manufacture some of its products, but this was terminated in 2003. Roche is now going on its own, and launching Avastin, its cancer drug, here, just a few months after its global launch. Dr G Telang, the company’s Managing Director, spoke to MG Arun on the new patent scenario and Roche’s future plans in India.